Lighthouse Investment Partners LLC purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 300,000 shares of the company's stock, valued at approximately $3,039,000. Lighthouse Investment Partners LLC owned approximately 1.34% of Oaktree Acquisition Corp. III Life Sciences as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in the company. K2 Principal Fund L.P. acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter worth $1,945,000. Shaolin Capital Management LLC acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter worth $5,478,000. Finally, AQR Arbitrage LLC acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter worth $19,743,000.
Oaktree Acquisition Corp. III Life Sciences Price Performance
OACC traded down $0.01 on Friday, hitting $10.45. 2,925 shares of the company were exchanged, compared to its average volume of 95,922. The business has a 50-day moving average price of $10.23. Oaktree Acquisition Corp. III Life Sciences has a twelve month low of $9.95 and a twelve month high of $10.85.
Oaktree Acquisition Corp. III Life Sciences Profile
(
Free Report)
Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.
Featured Stories
Before you consider Oaktree Acquisition Corp. III Life Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oaktree Acquisition Corp. III Life Sciences wasn't on the list.
While Oaktree Acquisition Corp. III Life Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
